Living immune cells as drug carriers in cancer therapy
-
Anja Philippi
Anja Philippi studied Biology at the University of Saarland (Saarbrücken, Germany). She conducted her doctoral thesis at the Biochemistry Center of the University of Heidelberg, Germany and the Biochemistry department of the University of Regensburg, Germany where she graduated in 2007. In May 2008, Dr. Philippi joined the Korea Institute of Science and Technology (KIST) Europe in Saarbrücken. After an initial phase as postdoctoral fellow, she became team leader of the Cellular Immunotherapy team in April 2010. Her research interests include cancer immunotherapies, cell-mediated drug delivery, nano-drug carriers, stimulus-sensitive drugs and the tumor microenvironment including tumor-associated macrophages.
André-René Blaudszun studied Biochemistry at the Ruhr-University Bochum, Germany. In 2007 he graduated and joined the Korea Institute of Science and Technology (KIST) Europe as a research assistant. Since 2010 he is enrolled as a PhD student at Saarland University in Saarbruecken, Germany. As a member of the Cellular Immunotherapy Team at KIST Europe and in cooperation with the Department of Biopharmaceutics and Pharmaceutical Technology at Saarland University his PhD work focuses on T lymphocyte-mediated drug delivery.
©2014 by Walter de Gruyter Berlin/Boston
Artikel in diesem Heft
- Cover and Frontmatter
- Notice from the Editorial Office
- News from the European Foundation for Nanomedicine (CLINAM)
- What’s up in nanomedicine?
- Introducing our Cover Contest Winner
- Living immune cells as drug carriers in cancer therapy
- Critical Review
- Towards nano-diagnostics for rapid diagnosis of infectious diseases – current technological state
- Original Articles
- Measurement of the size and charge distribution of sodium chloride particles generated by an Aeroneb Pro® pharmaceutical nebulizer
- Tailoring surface nanostructures on polyaryletherketones for load-bearing implants
- Opinion paper: Meeting report
- Nanomedicine: visions, risk, potential
- Corrigendum
- Nanoemulsions: increasing possibilities in drug delivery
Artikel in diesem Heft
- Cover and Frontmatter
- Notice from the Editorial Office
- News from the European Foundation for Nanomedicine (CLINAM)
- What’s up in nanomedicine?
- Introducing our Cover Contest Winner
- Living immune cells as drug carriers in cancer therapy
- Critical Review
- Towards nano-diagnostics for rapid diagnosis of infectious diseases – current technological state
- Original Articles
- Measurement of the size and charge distribution of sodium chloride particles generated by an Aeroneb Pro® pharmaceutical nebulizer
- Tailoring surface nanostructures on polyaryletherketones for load-bearing implants
- Opinion paper: Meeting report
- Nanomedicine: visions, risk, potential
- Corrigendum
- Nanoemulsions: increasing possibilities in drug delivery
